MedPath

Immediate Neurophysiological Effects of PENS on Radial Nerve in Patients With Lateral Epicondylalgia

Not Applicable
Completed
Conditions
Tennis Elbow
Interventions
Other: Sham PENS
Other: Real PENS
Registration Number
NCT04576195
Lead Sponsor
Universidad Complutense de Madrid
Brief Summary

Lateral epicondylalgia is a common musculoskeletal condition that approximately affects 1-3% of the general population. Several authors have found greater mechanical pain sensitivity in the radial nerve when compared with healthy subjects. Radial tunnel syndrome exhibits a similar clinical presentation to lateral epicondylalgia. Percutaneous electrical stimulation has shown reduce pain in several conditions. Percutaneous electrical stimulation on the radial nerve could cause an important relief in lateral epicondylalgia.

Hypothesis: Percutaneous electrical stimulation on radial nerve plus in patients with lateral epicondylalgia is better than sham percutaneous electrical stimulation

Detailed Description

Randomized, double-blind, placebo controlled clinical trial, using Percutaneous Electrical Nerve Stimulation (PENS). PENS is technique to provide a transcutaneous electrical nerve stimulation current throughout needling filaments place close to the nerve.

Study Aims:

Aim #1: The primary aim of the study is to compare the immediate effect of a single session of PENS on pressure pain sensitivity as measured by pressure pain threshold in patients with lateral epicondylalgia with random assignment to two treatments: PENS or Sham PENS

Aim #2: The secondary aim of the study is to compare the immediate effect on pain free grip strength, on intensity of pain as measured by visual analogue scale (VAS) in patients with lateral epicondylalgia with random assignment to two treatments: PENS or Sham PENS.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Lateral epicondylalgia symptoms confirmed with at least 2 of the 4 following test:

    1. pain during palpation of lateral epicondyle
    2. pain on resisted wrist extension
    3. pain on resisted middle finger extension
    4. pain during hand-grip
Exclusion Criteria
  • History of fractures, luxations, surgery and/or musculoskeletal disorders in upper limb.
  • Neurological disorders, inflammatory and/or degenerative diseases.
  • Having received as treatment techniques that involve needles on the previous 6 months to study enrollment, or having received percutaneous electrical stimulation as a treatment before.
  • Cervical pathology, fibromyalgia, unstable cardiovascular diseases, pregnant women or under suspect of pregnancy.
  • Contraindications of needle's insertions: anticoagulant therapy, needle phobia, diabetes, hypothyroidism, lymphoedema, muscular diseases).
  • Contraindications of electrical current application

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham PENSSham PENSOne single session of Sham-PENS
Real PENSReal PENSOne single session of PENS
Primary Outcome Measures
NameTimeMethod
Changes in Pressure pain threshold using an algometerBaseline and immediate (10 minutes after intervention)

Measurement of pressure pain threshold in the lateral epicondyle, radial nerve in the spiral groove, C5-C6 zygapophyseal joints, and the tibialis anterior muscle.

Secondary Outcome Measures
NameTimeMethod
Changes in Pain Intensity: Visual Analogue ScaleBaseline and immediate (10 minutes after intervention)

Pain intensity measured with a 100 mm (0 - No pain - 100 The worst pain) visual analogue scale

Changes in Pain-Free Grip StrengthBaseline and immediate (10 minutes after intervention)

Measurement the amount of force that the patient generates to the onset of pain as measured with a dynamometer

Changes in Self-perceived Improvement between baseline and follow-up periodsTime Frame: Baseline,10 minutes post-intervention

Global ratings on changes in regards to their level of elbow well-being since the treatment on a 15-point self-report scale (from -7, very much worse, to 7, completely recover)

Trial Locations

Locations (1)

Universidad Complutense de Madrid

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath